{"id":"placebo-for-vericiguat","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials to establish the efficacy of the active drug (vericiguat) through comparison. It contains no active pharmaceutical ingredient and produces no direct therapeutic effect beyond potential placebo response.","oneSentence":"This is a placebo control with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:32.189Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in vericiguat clinical trials for heart failure"}]},"trialDetails":[{"nctId":"NCT05714085","phase":"PHASE2, PHASE3","title":"Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-31","conditions":"Heart Failure, Left Ventricular Systolic Dysfunction","enrollment":342},{"nctId":"NCT05697640","phase":"PHASE2","title":"Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2023-06-22","conditions":"Post-COVID ME/CFS","enrollment":104},{"nctId":"NCT05711719","phase":"PHASE2","title":"Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2023-06-16","conditions":"Metabolic Syndrome, Coronary Microvascular Dysfunction","enrollment":45},{"nctId":"NCT06320951","phase":"PHASE2","title":"VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-12-01","conditions":"Cardiovascular Diseases, Insulin Sensitivity/Resistance, Metabolic Disease","enrollment":200},{"nctId":"NCT05093933","phase":"PHASE3","title":"A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-11-02","conditions":"Chronic Heart Failure With Reduced Ejection Fraction","enrollment":6106},{"nctId":"NCT05812755","phase":"PHASE4","title":"SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-05-19","conditions":"Endothelial Dysfunction, Vascular Diseases, Kidney Injury","enrollment":170},{"nctId":"NCT06671990","phase":"PHASE4","title":"The CardioMEMS Vericiguat Heart Failure Trial","status":"NOT_YET_RECRUITING","sponsor":"Finn Gustafsson","startDate":"2024-12-01","conditions":"Heart Failure, Pulmonary Arterial Hypertension","enrollment":17},{"nctId":"NCT03255512","phase":"PHASE1","title":"Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-08-17","conditions":"Coronary Artery Disease","enrollment":41},{"nctId":"NCT02617550","phase":"PHASE1","title":"Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-11-18","conditions":"Coronary Artery Disease","enrollment":36},{"nctId":"NCT02861534","phase":"PHASE3","title":"A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2016-09-20","conditions":"Heart Failure, Chronic Heart Failure With Reduced Ejection Fraction","enrollment":5050},{"nctId":"NCT01951625","phase":"PHASE2","title":"Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-11-29","conditions":"Heart Failure","enrollment":456},{"nctId":"NCT01951638","phase":"PHASE2","title":"Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-11-06","conditions":"Heart Failure","enrollment":477},{"nctId":"NCT03547583","phase":"PHASE2","title":"Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-06-15","conditions":"Chronic Heart Failure With Preserved Ejection Fraction","enrollment":789},{"nctId":"NCT03504982","phase":"PHASE1","title":"Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-05-17","conditions":"Coronary Artery Disease","enrollment":74}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":87,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo for vericiguat","genericName":"Placebo for vericiguat","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control with no active pharmacological mechanism. Used for Control arm in vericiguat clinical trials for heart failure.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}